IDT expands vax manufacturing and workforce

Vaccine manufacturer IDT Biologika will expand its viral vaccine facilities in Dessau-Rosslau. In addition, the German company will hire 80 additional workers for production. The company expects this expansion will increase their output four- to five-fold. IDT Biologika release

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.